MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.jtha.2026.04.036

Медицинская библиотека · Journal of thrombosis and haemostasis : JTH · 2026

Prevalence and outcomes of antiphospholipid syndrome after unprovoked venous thromboembolism: a multicenter real-world data analysis.

Mathur Abhinav, Cox Catrin, Banerjee Shabnam, Rees Marilyn, Roberts Lara, Breen Karen A, Lentaigne Claire, Alikhan Raza, Doyle Andrew J, Khan Mohammed M

СтатьяМногоцентровое исследованиеНаблюдательное исследованиеПеревод в очереди

Аннотация

BACKGROUND

Guidance for antiphospholipid antibody (aPL) testing after unprovoked venous thromboembolism (VTE) is inconsistent. Real-world data on the prevalence and outcomes of antiphospholipid syndrome (APS) in those presenting with unprovoked VTE are limited.

OBJECTIVES

This study determined APS prevalence after unprovoked VTE, compared outcomes from universal vs selective aPL testing, and assessed thrombosis recurrence in patients with APS within a multicenter UK cohort.

METHODS

This retrospective analysis included 897 patients with unprovoked VTE from 5 UK centers. One center used universal (n = 533) and 4 used selective (n = 364) aPL testing. The primary outcome was APS prevalence. Secondary outcomes included thrombosis-free survival by testing strategy and by anticoagulant (direct oral anticoagulants vs vitamin K antagonists) in patients with APS.

RESULTS

The overall APS prevalence was 11.7% and was higher in the universal testing than in the selective cohort (15.8% vs 5.8%). Baseline clinical features were poor predictors of APS. Among 105 patients with APS (median follow-up, 4.2 years), the annual thrombotic recurrence rate was 2.1 per 100 person-years. A nonsignificant trend toward higher recurrence was observed over time for direct oral anticoagulants vs vitamin K antagonists (3.8 vs 1.3 events/100 person-years; P = .16). No thrombosis-free survival difference was found between testing strategies (P = .71).

CONCLUSION

The prevalence of APS following unprovoked VTE is notable, and selective testing identified fewer APS cases in practice. Identifying aPLs in patients with unprovoked VTE may inform discussions regarding anticoagulation duration and choice, although optimal testing strategies require further prospective evaluation.

Для цитирования: Mathur Abhinav, Cox Catrin, Banerjee Shabnam, Rees Marilyn, Roberts Lara, Breen Karen A, Lentaigne Claire, Alikhan Raza, Doyle Andrew J, Khan Mohammed M. Prevalence and outcomes of antiphospholipid syndrome after unprovoked venous thromboembolism: a multicenter real-world data analysis.. Journal of thrombosis and haemostasis : JTH. 2026. DOI: 10.1016/j.jtha.2026.04.036.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.